http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-200501007-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0043 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-724 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-2271 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| filingDate | 2003-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2006-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EA-200501007-A1 |
| titleOfInvention | COMPOSITIONS AND METHODS FOR IMPROVED DELIVERY OF PEPTIDES CONNECTING WITH Y2-RECEPTORS THAT ARE PERFORMED THROUGH DEPOSITS AND TREATMENTS AND TREATMENTS AND TREATMENTS. |
| abstract | Pharmaceutical compositions and methods are disclosed that include at least one compound, which is a peptide YY, and one or more agents that promote intranasal delivery, for the improved delivery of peptide YY through the mucous membranes of the nasal cavity to treat a large number of diseases and conditions, including obesity, in mammalian subjects. In one aspect, these preparations and intranasal delivery methods provide improved delivery of peptide YY to plasma, or tissue, or central nervous system (CNS) fluid, for example, to obtain a peak concentration (C) of peptide YY in plasma, or tissue, or fluid Subject's CNS is 20% or higher compared to the peak concentration of YY peptide in the blood plasma, or tissue, or liquid of the subject's CNS after administering to the subject the same concentration or dose of YY peptide by subcutaneous injection. An international search report was published wired 2005.03.31. |
| priorityDate | 2002-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 41.